Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Keros Therapeutics, Inc.

NASDAQ: KROS · Life Sciences · 6 alerts · CIK 1664710

Share price
$10.03Close, Nov 16
Market cap
$197M
Shares outstanding
19.62MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Keros Therapeutics, Inc. filings on SEC EDGAR ↗

4:09 PM ET 8-K
Stock Buyback

Keros Therapeutics Announces $5M Stock Buyback

Keros Therapeutics announced that its Board of Directors approved a new $5 million share repurchase program for its common stock. The buyback authorization follows the company's receipt of a $20 million development milestone payment from Takeda Pharmaceuticals related to the clinical trial dosing of elritercept. Keros expects its current cash reserves, including this milestone, to fund operations into 2029.

Value
$5M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.